| 
June 11, 2023
Fate Therapeutics is Friday's top mover after declining 8.11%
Leading equity indices in the US rose as Dow Jones gained 0.13% and closed at 33,877. Nasdaq ended the session at 13,259 after a 0.16% gain.
“Top Movers” are assets that recorded the highest percentage change compared to their nearest peers. Friday's most active healthcare stocks are listed below.
Fate Therapeutics lost 8.11% during Friday's session; goes up in pre-market trading (+2.67% to $5)
More of the same from Friday's session: after ending Thursday at $5.3, Fate Therapeutics, Inc. dropped to $4.82 early in Friday's session and closed at $4.87. In total, it lost 8.11%. Currently, the clinical-stage biopharmaceutical company has a market capitalization of $499 million with an average daily trading volume of 1.94 million shares. So far this year, it has been under-performing the Nasdaq by 71.75%.
Friday's slide leaves HEXO Corp. traders hoping for a bounce
Friday's session continued down the same path: pronounced bearish market sentiment ensured that the high-quality cannabis producer made a notable 8.06% loss Friday, declining 7.2 cents and ultimately closing at 82.15 cents. The cannabis product maker's market cap currently stands at $38.50 million with an average daily volume of 328,107 shares.
HEXO Corp. is scheduled to announce earnings results tomorrow. The consensus EPS estimate is -0.01 and the consensus revenue estimate is $18.76 million.
Bearish mood pushes CureVac to session low of $9.67
CureVac shed 7.52%, falling to $9.71. CureVac has a market cap of $2.17 billion with an average daily trading volume of 573,870 shares. So far this year, it has performed better than the Nasdaq by 26.19%.
